期刊
PEDIATRICS
卷 125, 期 3, 页码 E600-E608出版社
AMER ACAD PEDIATRICS
DOI: 10.1542/peds.2008-3655
关键词
neurobehavioral behavior; selective serotonin reuptake inhibitor; prenatal exposure; serotonin
类别
资金
- Lundbeck Foundation [95092485]
- National Danish Research Foundation
- Aarhus University
- Danish Society of Obstetrics and Gynecology
- Ville Heise Foundation
- Rosalie Petersen Foundation
OBJECTIVE: The goal was to investigate a possible association between exposure to antidepressants in utero and developmental milestones in early childhood. METHODS: Information on pregnancy exposures and developmental milestones at 6 and 19 months was obtained from the Danish National Birth Cohort. Of the eligible pregnant women, 415 used antidepressant medication, 489 reported depression with no medical treatment, and 81 042 reported no depression and no use of psychotropic medication. RESULTS: Children with second- or third-trimester exposure to antidepressants were able to sit 15.9 days (95% confidence interval [CI]: 6.8-25.0) and to walk 28.9 days (95% CI: 15.0-42.7) later than children of women not exposed to antidepressants but still were within the normal range of development. Fewer children with second- or third-trimester exposure to antidepressants were able to sit without support at 6 months of age (odds ratio: 2.1 [95% CI: 1.23-3.60]), and fewer were able to occupy themselves at 19 months of age (odds ratio: 2.1 [95% CI: 1.09-4.02]). None of the other milestones measured showed statistically significant associations with antidepressant exposure. CONCLUSION: The results of this study suggest a permanent or reversible effect of antidepressant exposure on fetal brain development, which may depend on the timing of exposure during pregnancy. Pediatrics 2010;125:e600-e608
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据